Nisa Investment Advisors
VERV

Nisa Investment Advisors’s Verve Therapeutics VERV Stock Holding History

Nisa Investment Advisors’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,485
Closed -$84.1K – 3093
2025
Q2 		$84.1K Sell
7,485
-35,165
-82% -$200K ﹤0.01% 1448
2025
Q1 		$195K Sell
42,650
-131
-0.3% -$878 ﹤0.01% 1235
2024
Q4 		$241K Buy
42,781
+35,214
+465% +$199K ﹤0.01% 1241
2024
Q3 		$36.6K Sell
7,567
-147
-2% -$854 ﹤0.01% 1719
2024
Q2 		$37.6K Buy
7,714
+6,949
+908% +$43.7K ﹤0.01% 1742
2024
Q1 		$10.2K Buy
765
+107
+16% +$1.42K ﹤0.01% 2032
2023
Q4 		$9.17K Sell
658
-2,122
-76% -$26.3K ﹤0.01% 2057
2023
Q3 		$36.9K Sell
2,780
-40
-1% -$644 ﹤0.01% 1820
2023
Q2 		$52.9K Buy
2,820
+1,489
+112% +$24.8K ﹤0.01% 1737
2023
Q1 		$19K Hold
1,331
– – ﹤0.01% 2028
2022
Q4 		$26K Sell
1,331
-2
-0.2% -$53 ﹤0.01% 1981
2022
Q3 		$50K Buy
1,333
+233
+21% +$7.44K ﹤0.01% 1738
2022
Q2 		$17K Buy
+1,100
New +$17K ﹤0.01% 2092

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Nisa Investment Advisors's VERV Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 7,485 shares — an estimated $84.1K sold.

Nisa Investment Advisors first reported a position in VERV in Q2 2022 and held it in 13 quarters. The position peaked at $241K in Q4 2024. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 7,485 Verve Therapeutics shares in Q3 2025, an estimated $84.1K.
  • Nisa Investment Advisors first reported a position in Verve Therapeutics in Q2 2022 and held it in 13 quarters.
  • Nisa Investment Advisors's Verve Therapeutics position peaked at $241K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.